Table of Content
1. INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL NUCLEOTIDES SUPPLEMENTS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2. MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL NUCLEOTIDES SUPPLEMENTS MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET GUIDE
2.2.4 COMPANY POSITIONING GRID
2.2.5 COMAPANY MARKET SHARE ANALYSIS
2.2.6 MULTIVARIATE MODELLING
2.2.7 DEMAND AND SUPPLY-SIDE VARIABLES
2.2.8 CONSUMPTION TREND OF END PRODUCTS
2.2.9 TOP TO BOTTOM ANALYSIS
2.2.10 STANDARDS OF MEASUREMENT
2.2.11 VENDOR SHARE ANALYSIS
2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL NUCLEOTIDES SUPPLEMENTS MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3. MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
5.1 VALUE CHAIN ANALYSIS
5.2 SUPPLY CHAIN ANALYSIS
5.3 IMPORT-EXPORT ANALYSIS
5.4 PORTER’S FIVE FORCES ANALYSIS
5.4.1 BARGAINING POWER OF SUPPLIERS
5.4.2 BARGAINING POWER OF BUYERS/CONSUMERS
5.4.3 THREAT OF NEW ENTRANTS
5.4.4 THREAT OF SUBSTITUTE PRODUCTS
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
5.5 RAW MATERIAL SOURCING ANALYSIS
5.6 OVERVIEW OF TECHNOLOGICAL INNOVATIONS
5.7 INDUSTRY TRENDS AND FUTURE PERSPECTIVE
5.8 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS
5.9 FACTORS INFLUENCING PURCHASING DECISION OF END-USERS
6. IMPACT OF ECONOMIC SLOW DOWN ON MARKET
6.1 IMPACT ON PRICE
6.2 IMPACT ON SUPPLY CHAIN
6.3 IMPACT ON SHIPMENT
6.4 IMPACT ON COMPANY’S STRATEGIC DECISIONS
7. REGULATORY FRAMEWORK AND GUIDELINES
8. PRICING INDEX (PRICE AT B2B END & PRICES AT FOB)
9. PRODUCTION CAPACITY OF KEY MANUFACTURERES
10. BRAND OUTLOOK
10.1 COMPARATIVE BRAND ANALYSIS
10.2 PRODUCT VS BRAND OVERVIEW
11. GLOBAL NUCLEOTIDES SUPPLEMENTS MARKET, BY NITROGENOUS BASE, 2022-2029, (USD MILLION), (KILO TONS)
(ASP, VALUE & VOLUME WILL BE PROVIDED FOR ALL THE SEGMENTS)
11.1 OVERVIEW
11.2 PYRIMIDINE
11.2.1 PYRIMIDINE, BY TYPE
11.2.1.1. THYMINE
11.2.1.2. CYTOSINE
11.2.1.3. URACIL
11.3 PURINE
11.3.1 PURINE, BY TYPE
11.3.1.1. ADENINE
11.3.1.2. GUANINE
12. GLOBAL NUCLEOTIDES SUPPLEMENTS MARKET, BY FORM, 2022-2029, (USD MILLION)
12.1 OVERVIEW
12.2 LIQUID
12.3 POWDER
13. GLOBAL NUCLEOTIDES SUPPLEMENTS MARKET, BY SOURCE, 2022-2029, (USD MILLION)
13.1 OVERVIEW
13.2 NATURAL
13.3 ARTIFICIAL
14. GLOBAL NUCLEOTIDES SUPPLEMENTS MARKET, BY TECHNOLOGY, 2022-2029, (USD MILLION)
14.1 OVERVIEW
14.2 GENE CHIPS AND MICROARRAYS
14.3 SNP BY PYROSEQUENCING
15. GLOBAL NUCLEOTIDES SUPPLEMENTS MARKET, BY APPLICATION, 2022-2029, (USD MILLION)
15.1 OVERVIEW
15.2 PHARMACEUTICALS
15.2.1 PHARMACEUTICALS, BY TYPE
15.2.1.1. NOVEL DRUG FORMULATIONS
15.2.1.2. ONCOLOGICAL FORMULATIONS
15.2.1.3. PARENTERAL FORMULATIONS
15.2.1.4. TOPICAL MEDICINES
15.2.1.5. ORAL DRUGS
15.3 FOOD SERVICE
15.3.1 FOOD SERVICE, BY TYPE
15.3.1.1. MULTI UNIT RESTAURANTS
15.3.1.2. MEAL KITS
15.3.1.3. LODGING & HOSPITALITY
15.3.1.4. MILITARY & INSTITUTIONS
15.4 FOOD ADDITIVES
15.4.1 FOOD ADDITIVES, BY TYPE
15.4.1.1. ANTI-CAKING AGENTS
15.4.1.2. ANTIOXIDANTS
15.4.1.3. ARTIFICIAL SWEETENERS
15.4.1.4. EMULSIFIERS
15.4.1.5. FOOD ACIDS
15.4.1.6. COLOURS
15.4.1.7. HUMECTANTS
15.4.1.8. FLAVOURS
15.4.1.9. FLAVOUR ENHANCERS
15.4.1.10. FOAMING AGENTS
15.4.1.11. MINERAL SALTS
15.4.1.12. PRESERVATIVES
15.4.1.13. THICKENERS AND VEGETABLE GUMS
15.4.1.14. STABILISERS AND FIRMING AGENTS
15.4.1.15. FLOUR TREATMENT
15.4.1.16. GLAZING AGENT
15.4.1.17. GELLING AGENTS
15.4.1.18. PROPELLANTS
15.4.1.19. RAISING AGENTS
15.4.1.20. BULKING AGENTS
15.5 ANIMAL FEED ADDITIVES
15.5.1 ANIMAL FEED, BY ANIMAL TYPE
15.5.1.1. FISH / SHRIMP
15.5.1.2. PIGLETS
15.5.1.3. BROILER
15.5.1.4. RUMINANT
15.5.1.5. PORK
15.5.1.6. OTHERS
15.5.2 ANIMAL FEED ADDITIVES, BY TYPE
15.5.2.1. TECHNOLOGICAL ADDITIVES
15.5.2.1.1. E.G. PRESERVATIVES
15.5.2.1.2. ANTIOXIDANTS
15.5.2.1.3. EMULSIFIERS
15.5.2.1.4. ACIDITY
15.5.2.1.5. REGULATORS
15.5.2.1.6. SILAGE ADDITIVES
15.5.2.2. SENSORY ADDITIVES
15.5.2.3. NUTRITIONAL ADDITIVES
15.5.2.4. ZOOTECHNICAL ADDITIVES
15.5.2.5. COCCIDIOSTATS AND HISTOMONOSTATS
15.6 DRUG DISCOVERY
15.6.1 DRUG DISCOVERY, BY TYPE
15.6.1.1. CLASSICAL PHARMACOLOGY
15.6.1.2. REVERSE PHARMACOLOGY
15.7 HOSPITALS
15.8 CLINICS
15.9 NUTRACEUTICALS
15.9.1 NUTRACEUTICALS, BY TYPE
15.9.1.1. VITAMINS AND MINERALS
15.9.1.2. AMINO ACIDS
15.9.1.3. FATTY ACIDS
15.9.1.4. NATURAL MEDICAL PRODUCTS
15.10 OTHERS
16. GLOBAL NUCLEOTIDES SUPPLEMENTS MARKET, COMPANY LANDSCAPE, 2022-2029, (USD MILLION)
16.1 COMPANY SHARE ANALYSIS: GLOBAL
16.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
16.3 COMPANY SHARE ANALYSIS: EUROPE
16.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
16.5 MERGERS & ACQUISITIONS
16.6 NEW PRODUCT DEVELOPMENT & APPROVALS
16.7 EXPANSIONS & PARTNERSHIP
16.8 REGULATORY CHANGES
17. GLOBAL NUCLEOTIDES SUPPLEMENTS MARKET, BY GEOGRAPHY
17.1 GLOBAL NUCLEOTIDES SUPPLEMENTS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
17.2 NORTH AMERICA
17.2.1 U.S.
17.2.2 CANADA
17.2.3 MEXICO
17.3 EUROPE
17.3.1 GERMANY
17.3.2 U.K.
17.3.3 ITALY
17.3.4 FRANCE
17.3.5 SPAIN
17.3.6 RUSSIA
17.3.7 SWITZERLAND
17.3.8 TURKEY
17.3.9 BELGIUM
17.3.10 NETHERLANDS
17.3.11 DENMARK
17.3.12 SWEDEN
17.3.13 POLAND
17.3.14 NORWAY
17.3.15 FINLAND
17.3.16 REST OF EUROPE
17.4 ASIA-PACIFIC
17.4.1 JAPAN
17.4.2 CHINA
17.4.3 SOUTH KOREA
17.4.4 INDIA
17.4.5 SINGAPORE
17.4.6 THAILAND
17.4.7 INDONESIA
17.4.8 MALAYSIA
17.4.9 PHILIPPINES
17.4.10 AUSTRALIA
17.4.11 NEW ZEALAND
17.4.12 VIETNAM
17.4.13 TAIWAN
17.4.14 REST OF ASIA-PACIFIC
17.5 SOUTH AMERICA
17.5.1 BRAZIL
17.5.2 ARGENTINA
17.5.3 REST OF SOUTH AMERICA
17.6 MIDDLE EAST AND AFRICA
17.6.1 SOUTH AFRICA
17.6.2 EGYPT
17.6.3 BAHRAIN
17.6.4 UNITED ARAB EMIRATES
17.6.5 KUWAIT
17.6.6 OMAN
17.6.7 QATAR
17.6.8 SAUDI ARABIA
17.6.9 REST OF MEA
18. GLOBAL NUCLEOTIDES SUPPLEMENTS MARKET, SWOT & DBMR ANALYSIS
19. GLOBAL NUCLEOTIDES SUPPLEMENTS MARKET, COMPANY PROFILE
19.1 ADISSEO
19.1.1 COMPANY OVERVIEW
19.1.2 REVENUE ANALYSIS
19.1.3 GEOGRAPHICAL PRESENCE
19.1.4 PRODUCT PORTFOLIO
19.1.5 RECENT DEVELOPMENTS
19.2 AJINOMOTO CO., INC.
19.2.1 COMPANY OVERVIEW
19.2.2 REVENUE ANALYSIS
19.2.3 GEOGRAPHICAL PRESENCE
19.2.4 PRODUCT PORTFOLIO
19.2.5 RECENT DEVELOPMENTS
19.3 LEIBER
19.3.1 COMPANY OVERVIEW
19.3.2 REVENUE ANALYSIS
19.3.3 GEOGRAPHICAL PRESENCE
19.3.4 PRODUCT PORTFOLIO
19.3.5 RECENT DEVELOPMENTS
19.4 PHILEO BY LESAFFRE
19.4.1 COMPANY OVERVIEW
19.4.2 REVENUE ANALYSIS
19.4.3 GEOGRAPHICAL PRESENCE
19.4.4 PRODUCT PORTFOLIO
19.4.5 RECENT DEVELOPMENTS
19.5 ADM
19.5.1 COMPANY OVERVIEW
19.5.2 REVENUE ANALYSIS
19.5.3 GEOGRAPHICAL PRESENCE
19.5.4 PRODUCT PORTFOLIO
19.5.5 RECENT DEVELOPMENTS
19.6 BASF SE
19.6.1 COMPANY OVERVIEW
19.6.2 REVENUE ANALYSIS
19.6.3 GEOGRAPHICAL PRESENCE
19.6.4 PRODUCT PORTFOLIO
19.6.5 RECENT DEVELOPMENTS
19.7 CARGILL, INCORPORATED
19.7.1 COMPANY OVERVIEW
19.7.2 REVENUE ANALYSIS
19.7.3 GEOGRAPHICAL PRESENCE
19.7.4 PRODUCT PORTFOLIO
19.7.5 RECENT DEVELOPMENTS
19.8 LONZA
19.8.1 COMPANY OVERVIEW
19.8.2 REVENUE ANALYSIS
19.8.3 GEOGRAPHICAL PRESENCE
19.8.4 PRODUCT PORTFOLIO
19.8.5 RECENT DEVELOPMENTS
19.9 CHR. HANSEN HOLDING A/S
19.9.1 COMPANY OVERVIEW
19.9.2 REVENUE ANALYSIS
19.9.3 GEOGRAPHICAL PRESENCE
19.9.4 PRODUCT PORTFOLIO
19.9.5 RECENT DEVELOPMENTS
19.10 ELANCO
19.10.1 COMPANY OVERVIEW
19.10.2 REVENUE ANALYSIS
19.10.3 GEOGRAPHICAL PRESENCE
19.10.4 PRODUCT PORTFOLIO
19.10.5 RECENT DEVELOPMENTS
19.11 EVONIK INDUSTRIES AG
19.11.1 COMPANY OVERVIEW
19.11.2 REVENUE ANALYSIS
19.11.3 GEOGRAPHICAL PRESENCE
19.11.4 PRODUCT PORTFOLIO
19.11.5 RECENT DEVELOPMENTS
19.12 KEMIN INDUSTRIES, INC.
19.12.1 COMPANY OVERVIEW
19.12.2 REVENUE ANALYSIS
19.12.3 GEOGRAPHICAL PRESENCE
19.12.4 PRODUCT PORTFOLIO
19.12.5 RECENT DEVELOPMENTS
19.13 THERMO FISHER SCIENTIFIC INC
19.13.1 COMPANY OVERVIEW
19.13.2 REVENUE ANALYSIS
19.13.3 GEOGRAPHICAL PRESENCE
19.13.4 PRODUCT PORTFOLIO
19.13.5 RECENT DEVELOPMENTS
19.14 CJ CHEILJEDANG CORP.
19.14.1 COMPANY OVERVIEW
19.14.2 REVENUE ANALYSIS
19.14.3 GEOGRAPHICAL PRESENCE
19.14.4 PRODUCT PORTFOLIO
19.14.5 RECENT DEVELOPMENTS
19.15 MEIHUA HOLDINGS GROUP CO., LTD .
19.15.1 COMPANY OVERVIEW
19.15.2 REVENUE ANALYSIS
19.15.3 GEOGRAPHICAL PRESENCE
19.15.4 PRODUCT PORTFOLIO
19.15.5 RECENT DEVELOPMENTS
19.16 BIORIGIN
19.16.1 COMPANY OVERVIEW
19.16.2 REVENUE ANALYSIS
19.16.3 GEOGRAPHICAL PRESENCE
19.16.4 PRODUCT PORTFOLIO
19.16.5 RECENT DEVELOPMENTS
19.17 PROMEGA CORPORATION
19.17.1 COMPANY OVERVIEW
19.17.2 REVENUE ANALYSIS
19.17.3 GEOGRAPHICAL PRESENCE
19.17.4 PRODUCT PORTFOLIO
19.17.5 RECENT DEVELOPMENTS
19.18 AGILENT TECHNOLOGIES, INC
19.18.1 COMPANY OVERVIEW
19.18.2 REVENUE ANALYSIS
19.18.3 GEOGRAPHICAL PRESENCE
19.18.4 PRODUCT PORTFOLIO
19.18.5 RECENT DEVELOPMENTS
19.19 LALLEMAND INC.
19.19.1 COMPANY OVERVIEW
19.19.2 REVENUE ANALYSIS
19.19.3 GEOGRAPHICAL PRESENCE
19.19.4 PRODUCT PORTFOLIO
19.19.5 RECENT DEVELOPMENTS
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
20. RELATED REPORTS
21. QUESTIONNAIRE
22. ABOUT DATA BRIDGE MARKET RESEARCH
